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Abstract 
Review on t(2;18)(p11;q21)IGK/BCL2 and 
IGK/KDSR, and the dual role of the neighbor genes 
BCL2 and KDSR 
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Identity 
t(2;18)(p11;q21) is a very rare reciprocal 
translocation described only in a 13 cases with B-
lymphoproliferative disorders mainly follicular 
lymphomas (FL). The anomaly represents a minor 
variant of the classical t(14;18)(q32;q21) which is 
the most frequent translocation associated with 
follicular lymphoma (FL). In contrast to t(14;18) that 
juxtapose BCL2 with the heavy chain locus, t(2;18) 
resulted to the juxtaposition of the BCL2 to the 
kappa light chain locus. Despite of this difference the 
consequence of t(2;18) is the same as that in t(14;18) 
- deregulation of BCL2 leading to inhibition of 
apoptosis and respectively accumulation of a long 
living B-cells. A molecular variant of 
t(2;18)(p11;q21), in which the kappa light chain 
instead with BCL2 is rearranged with the coding 
region termed FVT-1 (for follicular lymphoma 
variant translocation - IGK/FVT-1), is also described 
Rimokh et al. (1993). It was ascertained later that 
FVT-1 coded the gene of 3-ketodihydroshingosine 
reductase (KDSR) - a key enzyme in the "de novo" 
synthetic pathway of ceramide. 
Clinics and pathology 
Disease 
Follicular lymphoma 
Phenotype/cell stem origin 
Germinal centre B-cells, the translocations appears 
at the pre B-stage of the B-cell differentiation. 
Epidemiology 
t(2;18)(p11;q21) is found in 8 cases (0.5% of all 
cases with abnormal karyotype) (Konishi H et al., 
1990; Leroux D et al., 1990;  Bertheas M-F et al., 
1991;  Juneja S et al., 1997;  Horsman DE et al., 
2001; Henderson L-J et al., 2004; Bentley G et al., 
2005;  Babu Rao V et al., 2006). The sex ratio is 
balanced M:F=1:1. The anomaly is observed mostly 
in older patients (average age 56 years; range 47-72). 
Cytogenetics 
t(2;18) as a sole anomaly is found only in one case. 
The other cases are with additional anomalies: 5 
cases are with 1 to 4 anomalies and 3 cases are with 
highly complex karyotypes. In three cases the 
stemline with t(2;18) is evaluated to subclones with 
secondary chromosome aberrations. 
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Additional anomalies Most of the additional 
anomalies frequently  associated with t(14;18) and 
FL are also present in the described cases with 
t(2;18): +12  (1 case), +7  (3 cases), 6q-  (1 case), +X  
(3 cases; one with additional deleted X in q22), +5  
(1 case), +8  (2 cases) and +der(18)t(2;18) (3 cases; 
one with 2 copies). In one case t(8;14)(q24;q32) is 
observed and in another two copies of its minor 
variant t(8;22)(q24q11) are present. Additional 
abnormalities of the following chromosomes are also 
described: chromosome 1 (3 cases - all of them are 
with 1p or 1q gains as a result of duplication of the 
segment 1q21q42  (one case) and unbalanced 
translocations of  the segments 1p11qter, 1q11qter 
and 1q21qter to the different recipient chromosomes 
including 1, 3, 9, 13 and 15), chromosome 3 (3 cases 
- two with -3, +3  and unbalanced translocations 
involving 3p11, q12 and q21 and one with 
t(3;3)(p21;q23) as a second anomaly in the 
stemline), chromosome 13 (2 cases - one with 
interstitial deletion of the segment q13q31  and one 
with translocation involving 13q34) and 
chromosome 15 (3 cases - one with interstitial 
deletion of the segment 15q12q15  and 
translocations involving  15q12, one with 
der(15)t(1;15)(p11;p11) and one with t(6;15)). Gains 
of 2p, 18 and 21 as well as losses of 1p, 10q and 17p 
that are frequently associated with FL with t(14;18) 
are not reported. 
 
Disease 
Other B-lymphoproliferative disorders 
 
Epidemiology 
(2;18) is found in 5 cases: 2 cases (0.14% of all cases 
with abnormal karyotype) with diffuse large B-cell 
lymphoma  (DLBCL) (females; one with age 56 
year)(Hillion J et al., 1991; Macpherson N et al., 
1999), 1 case (0.14% of all cases with abnormal 
karyotype) with mature B-cell neoplasm, NOS 
(MBCN) (male) (Tomita N et al,. 2009), 1 case 
(0.11% of all cases with abnormal karyotype) with 
Burkitt lymphoma/leukemia  (BL) (37-year-old 
female) (Hillion J et al.,1991) and 1 case (0.04% of 
all cases with abnormal karyotype) with chronic 
lymphocytic leukemia (CLL) (55-year-old male) 
(Dyer MJS et al., 1994). 
Cytogenetics 
Only the case with CLL is with one additional 
anomaly. All remaining cases are with complex 
karyotypes.  
 
Additional anomalies Some of the additional 
anomalies associated with t(14;18) are found: +12 (1 
case with CLL and 1 with DLBCL),  +X (1 case with 
DLBCL) and +18  (1 case with DLBCL). 
Abnormalities of chromosome 1 are reported in all 
cases except in the patient with CLL (1 case is with 
+der(1)(q12), 1 with  t(1;9)(p34;p22), 1 with 
i(1)(q10) and 1 with add(1)(p36)). Chromosome 3 
abnormalities is present in 2 cases with DLBCL - one 
is with add(3)(p25) and add(3)(q21) and one with 
t(3;22)(q27;q11). In  one case  with DLBCL 
t(8;14)(q24;q32) is described and in another with 
MBCN the same anomaly in combination with 
der(14)t(8;14)(q24;q32). 
Genes involved and 
proteins 
IGK (Immunoglobulin Kappa) 
Location 2p11.2 
DNA/RNA IGK contains approximately 40 
functional IgV (variable) genes, 5 IgKJ (Joining) 
genes and one IgKC (Constant) gene. 
Protein 
IGK encodes the immunoglobulin light chain kappa. 
The kappa chain is composed of an N-terminal 
variable region containing the antigen-binding site 
(encoded by one of the V and one of the J genes) and 
a C-terminal constant region (encoded by the C 
region gene). This structure of the Ig K chain is 
assembled by V-J rearrangement events followed by 
joining of the C gene to the V-J segment by RNA 
splicing. 
BCL2 (B-Cell Leukemia/Lymphoma 2) 
Location 18q21.3 
DNA/RNA BCL2 contains 3 exons and produces by 
alternative splicing 3 types of transcripts (a, b and c) 
encoding 2 different protein isoforms. 
Protein 
BCL2 belongs to the Bcl2 antiapoptotic Bcl2 family 
proteins (BCL2L2 (BCLW), MCL1, BCL2A1 
(BFL1)) that have similar 3D structure and four Bcl2 
homology (BH1-4) domains.  Bcl2 blocks cell death 
preventing the release of cytochrome c from the 
mitochondria by inactivating their proapoptotic Bcl2 
family counterparts ( BAX, BAK1, BCL2L11 
(BIM), BID, BAD, BIK, BMF) and by inhibition the 
inositol 1,4,5-triphosphate receptor (Rong YP et al., 
2009; Monaco G et al., 2012). 
KDSR (3-ketodihydrosphingosine 
reductase) 
Location 18q21.3 
DNA/RNA KDSR contains 10 exons and its 
transcription produces 13 different mRNAs, 11 
alternatively spliced variants and 2 unspliced forms. 
Protein 
KDSR encodes a putative secreted protein of 36kD 
that is a member of the short-chain 
dehydrogenases/reductases family. The protein 
localizes to the endoplasmic reticulum (ER) and 
catalyzes the reduction of 3-ketodihyrosphingosine 
to dihydrosphingosine in the "de novo" synthetic 
pathway of ceramide. Contains an N-terminal 
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transmembrane segment, followed by a large 
hydrophilic domain, 2 C-terminal transmembrane 
segments, and a KKxx-type endoplasmic reticulum 
(ER) retention signal at its C terminus. 
Result of the chromosomal 
anomaly 
Hybrid gene 
No hybrid gene is created. T(2;18) IgK/BCL2 leads 
to the juxtaposition of BCL2 near the enhancer 
sequences of the IgK gene. In contrast to the 
distribution of the breakpoints in BCL2 of the 
classical t(14;18) that are clustered in the majority of 
cases within the major (MBR) and minor breakpoint 
cluster region and more rarely within the 5'- flanking 
region of BCL2, the breakpoints in the BCL2 locus 
in t(2;18) occurs only in the 5' flanking region of the 
BCL gene termed the variant cluster region (VCR) 
(Larsen CJ et al., 1990; Hillion J et al., 1991; 
Bertheas M-F et al., 1992; Yabumoto K et al., 1996). 
The BCL2 coding region is not affected, because the 
breakpoints in VCR are distributed upstream of the 
translational initiation site of the BCL2 gene. On the 
other hand the locations of the breakpoints in the IgK 
gene are diverse. DNA breakage as a result of 5'-
BCL2/IgK junctions have been described in the 
region of the intronic sequences, joining segments 
and k-deleting element (Yonetani N et al., 2001). In 
some cases with t(2;18) head-to-tail configuration of 
the BCL2 and IgK genes have been recognized. In 
the molecular variant IgK/KDSR (FVT-1) the 
breakpoints on 18q21 and 2p11 occurred in the last 
intron of FVT-1 and within the J4 segment of the Jk 
region respectively. As a result of the translocation 
the promoting region and the 5' part of the coding 
sequence of FVT-1 is juxtaposed to the Vk -Jk region 
of the kappa light chain on the der(2) chromosome. 
Fusion protein 
Fusion protein in the cases with BCL2/IgK 
rearrangements is not produced. The kappa 
immunoglobulin enhancer induces BCL2 
overexpression. 
Oncogenesis 
The consequence of t(2;18) is the same as in the 
t(14;18). The overproduction of the Bcl2 protein 
blocks the apoptosis and promotes prolonged B-cell 
survival. But the differences in the molecular 
structure of both rearrangements possibly predispose 
difference in the levels of BCL2 expression. It was 
found that the cases and tumor cell lines with 5'-
BCL2/Ig (including 5'-BCL2/IgK) rearrangements 
have markedly higher levels of BCL transcripts (as 
well as expression of BCL2 protein by 
immunocytochemistry staining) than those of 
BCL2/IgH with breakpoints in MBR or 3'-MBR 
(Dyer MJS et al., 1993; Yonetani N et al., 2001). In 
the molecular variant IgK/FVT-1 the FVT-1 
disruption resulted in the constitution of a chimeric 
Vk -Jk-5' FVT-1 gene in a tail-to-tail configuration. 
On the other hand the BCL2 is juxtaposed to the 
kappa light chain locus in the vicinity of the 5' kappa 
gene enhancer leading to its overexpression. 
Therefore the molecular pathogenesis of this variant 
of t(2;18) is also linked to the deregulation of BCL2 
and not to the FVT-1. 
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